Biotransformation of Natural and Synthetic Isoflavonoids by Two Recombinant Microbial Enzymes

  • Michael Seeger
    Laboratorio de Microbiología Molecular y Biotecnología Ambiental, Departamento de Química, Universidad Técnica Federico Santa María, Valparaíso
  • Myriam González
    Laboratorio de Microbiología Molecular y Biotecnología Ambiental, Departamento de Química, Universidad Técnica Federico Santa María, Valparaíso
  • Beatriz Cámara
    Laboratorio de Microbiología Molecular y Biotecnología Ambiental, Departamento de Química, Universidad Técnica Federico Santa María, Valparaíso
  • Liliana Muñoz
    Laboratorio de Microbiología Molecular y Biotecnología Ambiental, Departamento de Química, Universidad Técnica Federico Santa María, Valparaíso
  • Emilio Ponce
    Laboratorio de Microbiología Molecular y Biotecnología Ambiental, Departamento de Química, Universidad Técnica Federico Santa María, Valparaíso
  • Lorenzo Mejías
    Laboratorio de Química Médica y Ensayos Biológicos, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile
  • Carolina Mascayano
    Laboratorio de Química Médica y Ensayos Biológicos, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile
  • Yesseny Vásquez
    Laboratorio de Química Médica y Ensayos Biológicos, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile
  • Silvia Sepúlveda-Boza
    Laboratorio de Química Médica y Ensayos Biológicos, Facultad de Ciencias Médicas, Universidad de Santiago de Chile, Santiago, Chile

説明

<jats:title>ABSTRACT</jats:title> <jats:p> Isolation and synthesis of isoflavonoids has become a frequent endeavor, due to their interesting biological activities. The introduction of hydroxyl groups into isoflavonoids by the use of enzymes represents an attractive alternative to conventional chemical synthesis. In this study, the capabilities of biphenyl-2,3-dioxygenase (BphA) and biphenyl-2,3-dihydrodiol 2,3-dehydrogenase (BphB) of <jats:italic>Burkholderia</jats:italic> sp. strain LB400 to biotransform 14 isoflavonoids synthesized in the laboratory were investigated by using recombinant <jats:italic>Escherichia coli</jats:italic> strains containing plasmid vectors expressing the <jats:italic>bphA1A2A3A4</jats:italic> or <jats:italic>bphA1A2A3A4B</jats:italic> genes of strain LB400. The use of BphA and BphB allowed us to biotransform 7-hydroxy-8-methylisoflavone and 7-hydroxyisoflavone into 7,2′,3′-trihydroxy-8-methylisoflavone and 7,3′,4′-trihydroxyisoflavone, respectively. The compound 2′-fluoro-7-hydroxy-8-methylisoflavone was dihydroxylated by BphA at <jats:italic>ortho</jats:italic> -fluorinated and <jats:italic>meta</jats:italic> positions of ring B, with concomitant dehalogenation leading to 7,2′,3′,-trihydroxy-8-methylisoflavone. Daidzein (7,4′-dihydroxyisoflavone) was biotransformed by BphA, generating 7,2′,4′-trihydroxyisoflavone after dehydration. Biotransformation products were analyzed by gas chromatography-mass spectrometry and nuclear magnetic resonance techniques. </jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ